Background: The well-known insertion/deletion polymorphism (rs4646994) of the angiotensin-converting enzyme (ACE) gene has been previously associated with obesity, blood flow, muscular strength, and ACE enzyme activity. Despite the relevant role of ACE in homeostasis, few data are currently available on the relationship between rs4646994 and hydration status. Thus, we tested the association between the ACE Ins/Del polymorphism, body composition, and hydration status in a young Italian population. Methods: A total of 306 healthy children and adolescents who regularly practice sports were recruited. Anthropometric, bioimpedentiometric parameters, and urine samples were collected, while ACE rs4646994 genotyping was performed on DNA from buccal swabs. General linear models were used for association testing. Results: The ACE Ins/Del polymorphism was associated with body composition. Ins/Ins individuals had higher phase angle (PhA) and body cellular mass index (BCMI) values. A significant influence of the ACE rs4646994 according to hydration status on body composition was also identified. In particular, Ins/Ins individuals displayed higher PhA and BCMI values only if norm-hydrated, while they showed values similar to Del carriers if dehydrated. Conclusion: Our results confirm the relationship between the ACE Ins/Del polymorphism and body composition and suggest a role for hydration status in modulating this relationship. These interesting preliminary results warrant further investigation to disentangle the genetic role of ACE on hydration homeostasis.

Keywords:
Angiotensin-converting enzyme gene, Body composition, Phase angle, Body cellular mass index, Hydration, Urine specific gravity
1.
Assael BM, Cipolli M, Meneghelli I, Passiu M, Cordioli S, Tridello G, et al: Italian children go to school with a hydration deficit. J Nutr Disorders Ther 2012;2:3.
2.
Stookey JD, Brass B, Holliday A, Arieff A: What is the cell hydration status of healthy children in the USA? Preliminary data on urine osmolality and water intake. Public Health Nutr 2012;15:2148-2156.
3.
Berneis K, Ninnis R, Haussinger D, et al: Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans. Am J Physiol 1999;276, 188-195.
4.
Brown CM, Barberini L, Dulloo AG, et al: Cardiovascular responses to water drinking: does osmolality play a role? Am J Physiol Regul Integr Comp Physiol 2005;289:1687-1692.
5.
Judelson DA, Maresh CM, Yamamoto LM, et al: Effect of hydration state on resistance exercise-induced endocrine markers of anabolism, catabolism, and metabolism. J Appl Physiol 2008;105:816-824.
6.
McKenzie MA, Greenleaf JE, Looft-Wilson R, et al: Leucocytosis, thrombocytosis, and plasma osmolality during rest and exercise: a hypothesis. J Physiol Pharmacol 1999;50:259-273.
7.
Cheung SS, McLellan TM: Heat acclimation, aerobic fitness, and hydration effects on tolerance during uncompensable heat stress. J Appl Physiol 1998;84:1731-1739.
8.
Ainslie PN, Campbell IT, Frayn KN, et al: Energy balance, metabolism, hydration, and performance during strenuous hill walking: the effect of age. J Appl Physiol 2002;93:714-723.
9.
Muckelbauer R, Sarganas G, Gruneis A, Muller-Nordhorn J: Association between water consumption and body weight outcomes: a systematic review. Am J Clin Nutr 2013;98:282-299.
10.
Bossingham MJ, Carnell NS, Campbell WW: Water balance, hydration status, and fat-free mass hydration in younger and older adults. AmJ Clin Nutr 2005;81:1342-1350.
11.
Crisan D, Carr J: Angiotensin I-converting enzyme. JMD 2000;2:105-115.
12.
Paul M, Mehr ALIP, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803.
13.
Engelis S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM: Co-expression of local renin angiotensin system genes in human adipose tissue. J Hypertens 1999;17:555-560.
14.
Eisenmann JC, Sarzynski MA, Glenn K, Rothschild M, Heelan KA: ACE I/D genotype, adiposity, and blood pressure in children. Cardiovasc Diabetol 2009;8:14.
15.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
16.
Ma F, Yang Y, Li X, Zhou F, Gao C, Li M, et al: The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One 2013;8:54685.
17.
Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, Dollery C, et al: Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999;353:541-545.
18.
Murphy AJ, Davies PS: Body cell mass index in children: interpretation of total body potassium results. Br J Nutr 2008;100:666-668.
19.
Oliveira CM, Kubrusly M, Mota RS, Silva CA, Choukroun G, Oliveira VN: The phase angle and mass body cell as markers of nutritional status in hemodialysis patients. J Ren Nutr 2010;20:314-320.
20.
Montazer S, Farshad AA, Monazzam MR, Eyvazlou M, Yaraghi AA, Mirkazemi R: Assessment of construction workers' hydration status using urine specific gravity. Int J Occup Med Environ Health 2013;26:762-769.
21.
McCauley T, Mastana SS, Hossack J, Macdonald M, Folland JP. Human angiotensin-converting enzyme I/D and alpha-actinin 3 R577X genotypes and muscle functional and contractile properties. Exp Physiol 2009;94:81-89.
22.
Marcos A, Manonelles P, Palacios N, Wärnberg J, Casajús JA, Pérez M, et al: Physical activity, hydration and health. Nutr Hosp 2014;29:1224-1239.
23.
Ritz P, Vol S, Berrut G, Tack I, Arnaud MJ, Tichet J: Influence of gender and body composition on hydration and body water spaces. Clin Nutr 2008;27:740-746.
24.
Mărginean CO, Bănescu C, Duicu C, Voidăzan S, Mărginean C: Angiotensin-converting enzyme gene insertion/deletion polymorphism in nutritional disorders in children. Eur J Nutr 2015;54:1245-1254.
25.
Mao S, Huang S: A meta-analysis of the association between angiotensin-converting enzyme insertion/ deletion gene polymorphism and the risk of overweight/obesity. J Renin Angiotensin Aldosterone Syst 2015;16:687-694.
26.
Shunmugam V, Say YH: Evaluation of association of ADRA2A rs553668 and ACE I/D gene polymorphisms with obesity traits in the Setapak population, Malaysia. Iran Red Crescent Med J 2016;18:e22452.
27.
Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van Someren K, Montgomery HE: The ACE gene and human performance: 12 years on. Sports Med 2011;41:433-448.
28.
Fukushima Y, Kurose S, Shinno H, et al: Importance of lean muscle maintenance to improve insulin resistance by body weight reduction in female patients with obesity. Diabetes Metab J 2016;40:147-153.
29.
Ezeh U, Pall M, Mathur R, Azziz R: Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Human Reprod 2014;29:1508-1517.
30.
Alvarez R, Terrados N, Ortolano R, et al: Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000;82:117-120.
31.
Kritchevsky SB, Nicklas BJ, Visser M, et al: Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. JAMA 2005;294:691-698.
32.
Williams AG, Rayson MP, Jubb M, et al: The ACE gene and muscle performance. Nature 2000;403:614.
33.
Thornton SN: Increased hydration can be associated with weight loss. Front Nutr 2016;3:18.
34.
Thornton SN: Thirst and hydration: physiology and consequences of dysfunction. Physiol Behav 2010;100:15-21.
35.
Thornton SN: Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer. J Intern Med 2009;265:616-617.
36.
Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TA, Tai ES, et al: Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. J Nutrigenet Nutrigenomics 2011;4:69-89.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.